Nuvation Bio's FDA approval for IBTROZI isn't boosting its stock. Learn about NUVB's financial risks, valuation concerns, and ...

It is “somewhat surprising” the Federal Reserve still projects two interest-rate cuts this year while revising its inflation expectations higher, according to Seema Shah, chief global strategist at ...

The U.S. economy is on track to slow in 2025 as households and businesses grapple with higher prices stemming from U.S. tariffs, the Federal's Reserve latest forecast shows. Gross domestic product, ...

Automatic Data Processing engages in the provision of cloud-based HCM solutions worldwide. Check out why we initiate ADP ...

So, it's not surprising that Oracle is benefiting from this momentum. And this growth story has been so solid in the past ...

According to analysts today, AWS remains Amazon's "crown jewel." It should allow Amazon to tap into the high and sustained ...

The price of Brent Crude this morning resumed its upward momentum, although the rise of 1% still left it $4 short of the $78 ...

Deadpool & Wolverine has grossed over $1 billion worldwide this summer and is the alltime highest earning R-rated box-office ...

Sacheerome IPO made a record-breaking debut in the stock market today. The stock listed on the NSE SME platform at Rs. 153 ...

Even the slightest whiff of trouble with future earnings could ruin the stock market's improved outlook. What investors need ...

The S&P 500 (SNPINDEX: ^GSPC), a benchmark for the broader U.S. stock market, has had one of the most volatile years on ...

Zip raises cash earnings forecast to $160m as buy-now-pay-later fintech sees strong US performance. Analysts maintain $3 ...